SCHEMBL637452

SCHEMBL637452

NC(=O)C[C@H](N)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
PKM P14618 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
SLC6A3 Q01959 3/20 0.48
DRD3 P35462 2/20 0.48
LMNA P02545 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
EDNRB P24530 1/20 0.48
MAPK1 P28482 1/20 0.48
MC4R P32245 1/20 0.48
MC3R P41968 1/20 0.48
DRD2 P14416 1/20 0.48
GABBR2 O75899 1/20 0.47
GABBR1 Q9UBS5 1/20 0.47
EPHX1 P07099 1/20 0.46
ALDH1A1 P00352 1/20 0.45
BCAT2 O15382 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL637029 1.00 CYP2C19 (0.53) CYP2C19SMN1; SMN2CYP1A2CYP2D6PKM
SCHEMBL1231305 1.00 CYP2C19 (0.53) CYP2C19SMN1; SMN2CYP1A2CYP2D6PKM
SCHEMBL59840 0.84 GABBR2 (0.59) CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1
SCHEMBL288753 0.84 GABBR2 (0.59) CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1
SCHEMBL123765 0.84 GABBR2 (0.59) CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1
SCHEMBL28450957 0.84 GABBR2 (0.48) CYP2C19SMN1; SMN2CYP2D6LMNAMAPK1
Hydrochloric Acid SCHEMBL2934796 0.83 GABBR2 (0.57) CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1
SCHEMBL22685292 0.83 GABBR2 (0.47) CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1
SCHEMBL9386161 0.83 GABBR2 (0.57) CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1
Hydrochloric Acid SCHEMBL3874351 0.83 GABBR2 (0.57) CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119364-B2 Methods for generating analogs of coenzyme A THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-21 US disclosed
US-20100304430-A1 Methods for Generating Analogs of Coenzyme A THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-12-02 US disclosed
US-7727738-B2 Methods for generating analogs of coenzyme A THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-06-01 US disclosed
US-20070128683-A1 Metabolic delivery of coenzyme A analogs NATIONAL SCIENCE FOUNDATION 2007-06-07 US disclosed
US-6914160-B1 Oxytocin inhibitors PFIZER INC (US) 2005-07-05 US disclosed
EP-1537085-A1 OXYTOCIN INHIBITORS Pfizer Limited (GB) 2005-06-08 EP disclosed
WO-2004020414-A1 OXYTOCIN INHIBITORS PFIZER LIMITED (GB) 2004-03-11 WO disclosed
WO-2004020414-A1 OXYTOCIN INHIBITORS PFIZER LIMITED (GB) 2004-03-11 WO disclosed